# Evaluating the Impact of a Value-based Prescription Drug Formulary

> **NCT04904055** · — · COMPLETED · sponsor: **Kaiser Permanente** · enrollment: 36333 (actual)

## Conditions studied

- Value-Based Health Insurance

## Interventions

- **OTHER:** Value-based Formulary

## Key facts

- **NCT ID:** NCT04904055
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 36333 (ACTUAL)
- **Last updated:** 2021-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904055, "Evaluating the Impact of a Value-based Prescription Drug Formulary". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04904055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*